Test Price
2,800 AED✅ Home Collection Available
BTK Gene Agammaglobulinemia and Isolated Hormone Deficiency Genetic Test in UAE | 2800 AED | DHA Approved
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
BTK gene analysis by Next-Generation Sequencing (NGS) simultaneously detects all clinically relevant variants in the BTK gene (Xq22.1), clarifying the dual phenotype of X‑linked agammaglobulinemia and isolated hormone deficiency. This method provides comprehensive coverage of coding regions and splice sites, exceeding 99.9% analytical sensitivity.
| Feature | Our BTK Genetic Test | Alternative (BTK Single-Gene Sequencing) |
|---|---|---|
| Precision | Full coding region + splice sites, >99.9% analytical sensitivity, includes CNV detection | Limited to selected exons; may miss deep intronic variants |
| Methodology | NGS with high-depth coverage, validated per international standards | Sanger sequencing, no dosage analysis |
| Turnaround Time | 14–21 calendar days | 4–6 weeks |
Physician Insight & Safety Protocols
“BTK gene variants can present with both recurrent sinopulmonary infections and subtle hormonal imbalances. Interpret results cautiously and always correlate with clinical findings and a detailed family history. Your child’s wellbeing is our priority—no test replaces a thorough clinical evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Considerations
- Do not discontinue prescribed medication without consulting your doctor.
- Genetic test results should be interpreted by a qualified clinician in the context of the patient’s full medical history and physical examination.
- Carrier status and predictive testing for minors require written informed consent from the legal guardian in line with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Safety Exclusion Criteria & Emergency Red Flags
- Active severe infection requiring immediate hospitalisation—postpone elective blood draw.
- Recent blood transfusion (< 4 weeks) or bone marrow transplant may interfere with DNA analysis.
- If the patient is a minor, written consent from legal guardian is mandatory.
- ER Red Flags: Sudden high fever with neutropenia, septic shock, or new‑onset severe endocrine crisis (adrenal insufficiency) warrant emergency care before scheduling collection.
Patient FAQ & Clinical Guidance
1. What does the BTK NGS detect that a standard immunoglobulin panel cannot?
This NGS assay identifies exact pathogenic BTK mutations responsible for agammaglobulinemia and associated hormone deficiency, even in carriers and asymptomatic at‑risk relatives. It clarifies the genetic etiology when immunoglobulin levels are borderline or normal.
2. Can I use a dried blood spot (FTA card) instead of a venous blood draw?
Yes, one drop of blood on an FTA card is sufficient for high‑quality DNA extraction and full NGS analysis. Our temperature‑controlled courier service ensures specimen stability from your doorstep to the laboratory.
3. How long until I receive the results and how will they be explained?
Results are ready in 14–21 days and include a complimentary telephonic genetic counselling session with a DHA‑licensed clinician for interpretation.
UAE Regulatory & Data Privacy Adherence
Data Protection: This test complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient genetic data is encrypted and processed solely for diagnostic purposes.
Accreditation: Testing facility holds ISO 9001:2015 Certification (INT/EGQ/2509DA/3139). All procedures conform to DHA regulatory standards for genetic testing.
Consent: Written informed consent obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient autonomy and confidentiality.
Clinical & Logistical Metadata
| Test Name | BTK Gene Agammaglobulinemia and Isolated Hormone Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 14–21 calendar days |
| Sample Type / Matrix | Blood (Peripheral Whole Blood) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM–11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Detection |
| ICD-10-CM Code | D80.0, E23.0, Z14.8 |
| LOINC Code | 82939-0 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians